Xtl biopharmaceuticals ltd (XTLB)
Balance Sheet / Quarterly
Dec'17Dec'16
CURRENT ASSETS:
Cash and cash equivalents

3,289

2,019

Short term bank deposit

2,507

0

Marketable securities

298

414

Other accounts receivable

112

321

Total current assets

6,206

2,754

NON-CURRENT ASSETS:
Property and equipment, net

0

10

Intangible assets, net

380

253

Total non-current assets

380

263

Total assets

6,586

3,017

CURRENT LIABILITIES:
Trade payables

4

17

Other accounts payable

296

313

Total current liabilities

300

330

NON-CURRENT LIABILITIES:
WARRANTS AT FAIR VALUE

2,667

0

EQUITY ATTRIBUTABLE TO EQUITY HOLDERS OF THE COMPANY:
Share capital - ordinary shares of NIS 0.1 par value: Authorized - December 31, 2017 and 2016 - 1,450,000,000 and 700,000,000 shares, respectively; Issued and outstanding - December 31, 2017 and 2016 - 514,205,799 and 274,205,799 shares, respectively

13,182

6,624

Premium on shares, options and warrants

146,015

150,784

Reserve from transactions with non-controlling interests

20

20

Other comprehensive income

47

163

Accumulated deficit

-155,645

-154,904

Total equity

3,619

2,687

Total liabilities and equity

6,586

3,017